Sleep Aids (Pharmacies) - Saudi Arabia

Saudi Arabia

Highlights

Revenue in the Sleep Aids market is projected to reach US$15.72m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.53%, resulting in a market volume of US$16.15m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.42 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Sleep Aids (Pharmacies) market in Saudi Arabia is experiencing significant growth and development.

Customer preferences: Saudi Arabia has a high prevalence of sleep disorders, with a large portion of the population suffering from insomnia and other sleep-related issues. This has led to an increased demand for sleep aids in the country. Customers are seeking effective solutions to improve their sleep quality and overall well-being. They are looking for sleep aids that are safe, non-addictive, and easily accessible. Convenience is also an important factor, with customers preferring to purchase sleep aids from pharmacies rather than seeking medical prescriptions.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Saudi Arabia is the growing popularity of natural and herbal sleep aids. Customers are increasingly seeking alternative remedies that are perceived to be safer and have fewer side effects. This trend is driven by a general shift towards natural and holistic wellness solutions. As a result, pharmacies are stocking a wider range of natural sleep aids, including herbal teas, supplements, and aromatherapy products. Another trend in the market is the increasing availability of over-the-counter sleep aids. Previously, most sleep aids in Saudi Arabia required a prescription from a healthcare professional. However, there has been a relaxation of regulations, allowing certain sleep aids to be sold over-the-counter. This has made it more convenient for customers to access sleep aids without the need for a doctor's visit. Pharmacies are capitalizing on this trend by expanding their sleep aids product offerings and providing more information and guidance to customers.

Local special circumstances: Saudi Arabia has a young and growing population, with a high percentage of the population under the age of 30. This demographic trend is driving the demand for sleep aids, as younger individuals are more likely to experience sleep disturbances due to lifestyle factors such as stress, irregular work schedules, and excessive screen time. Additionally, the fast-paced and competitive nature of modern life in Saudi Arabia has contributed to an increase in sleep disorders, further fueling the demand for sleep aids.

Underlying macroeconomic factors: The Sleep Aids (Pharmacies) market in Saudi Arabia is also influenced by underlying macroeconomic factors. The country has been experiencing economic growth, which has led to an increase in disposable income among the population. As a result, people have more purchasing power and are willing to spend on products that improve their quality of life, including sleep aids. Furthermore, the government's focus on healthcare and wellness initiatives has created a supportive environment for the growth of the sleep aids market. This includes investments in healthcare infrastructure, awareness campaigns, and regulatory reforms to ensure the availability of safe and effective sleep aids in pharmacies. In conclusion, the Sleep Aids (Pharmacies) market in Saudi Arabia is developing due to customer preferences for safe and accessible solutions to sleep disorders. The market is experiencing trends such as the popularity of natural sleep aids and the availability of over-the-counter products. Local special circumstances, including a young population and a fast-paced lifestyle, contribute to the demand for sleep aids. Underlying macroeconomic factors, such as economic growth and government support, further drive the development of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.